Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gjonaj, S. T.
Right arrow Articles by Dozor, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gjonaj, S. T.
Right arrow Articles by Dozor, A. J.
(Chest. 1997;112:1665-1669.)
© 1997 American College of Chest Physicians

Nebulized Lidocaine Administered to Infants and Children Undergoing Flexible Bronchoscopy

Suzette T. Gjonaj MD1; Diana B. Lowenthal MD, FCCP1; and Allen J. Dozor MD1

1 From the Division of Pediatric Pulmonology, New York Medical College, Valhalla

Study objectives: The purpose of this study was to evaluate the safety and efficacy of nebulized lidocaine hydrochloride as a topical anesthetic for use during flexible bronchoscopy in infants and children.

Design: This was a prospective, randomized, double-blind study.

Patients: Twenty consecutive patients scheduled for flexible bronchoscopy who were not intubated and had no known cardiac or hepatic disease comprised the study group.

Interventions: The patients were randomized to receive either 8 mg/kg or 4 mg/kg of nebulized 2% lidocaine by face mask prior to bronchoscopy.

Setting: The study took place in a bronchoscopy suite at an academic medical center.

Measurements: To determine systemic absorption, serum lidocaine levels were obtained. To assess efficacy of nebulized lidocaine as a topical anesthetic, changes in heart rate and blood pressure were recorded, and the bronchoscopist (who did not know the lidocaine dose used) rated the ease of passage of the bronchoscope through nose, vocal cords, trachea, bronchi, and all sites overall, and the degree of cough.

Results: Nebulized lidocaine was safe, was well-tolerated, and provided adequate anesthesia for half of the patients. The serum lidocaine levels were much lower than the levels in the toxic range. There was a trend toward easier passage of the bronchoscope in the high-dose group at all sites noted previously that were evaluated.

Conclusion: Nebulized lidocaine in doses up to 8 mg/kg appears to be safe and moderately effective as a topical anesthetic for flexible bronchoscopy in infants and children. The serum levels were remarkably low. Fifty percent of the subjects required no supplemental lidocaine.

Key Words: anesthesia • bronchoscopy • lidocaine • nebulizer • pediatrics

Submitted on September 12, 1996
Accepted on June 20, 1997




This article has been cited by other articles:


Home page
 ChestHome page
D. Stolz, P. N. Chhajed, J. Leuppi, E. Pflimlin, and M. Tamm
Nebulized Lidocaine for Flexible Bronchoscopy: A Randomized, Double-Blind, Placebo-Controlled Trial
Chest, September 1, 2005; 128(3): 1756 - 1760.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American College of Chest Physicians.